Lasmiditan mechanism of action – review of a selective 5-HT 1F agonist | The Journal of Headache and Pain | Full Text

Lasmiditan mechanism of action – review of a selective 5-HT 1F agonist | The Journal of Headache and Pain | Full Text

Lasmiditan mechanism of action – review of a selective 5-HT1F agonist

Migraine is a leading cause of disability worldwide, but it is still underdiagnosed and undertreated. Research on the pathophysiology of this neurological disease led to the discovery that calcitonin gene-rela...

Authors:David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, Michael H. Ossipov, Ann M. Hake and Andrew M. Blumenfeld

Citation:The Journal of Headache and Pain 2020 21:71

Content type:Review article

 

Published on: 10 June 2020

• ViewFull Text
 
• ViewPDF